Startups Swimming i...
Health Care: Drugs
ImmunoCellular Therapeutics Limited (IMUC: AMEX)
$2.52 -0.03 | -1.18%
05/24/13 - 09:30 AM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 0.00 | 0.00 | 0.00 | 300.00K |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 0.00 | 0.00 | 0.00 | 300.00K |
| Selling, General, and Administrative Expenses | 4.12M | 3.64M | 2.84M | 1.99M |
| Research & Development | 7.71M | 4.99M | 2.29M | 962.53K |
| Operating Income before D & A (EBITDA) | -11.83M | -8.63M | -5.14M | -2.65M |
| Depreciation & Amortization | 45.82K | 20.36K | 3.63K | 3.40K |
| Interest Income | 8.61K | 4.35K | 4.10K | 22.04K |
| Other Income - Net | -2.28M | 2.90M | -1.02M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -14.14M | -5.74M | -6.15M | -2.63M |
| Interest Expense | 397.29K | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -14.54M | -5.74M | -6.15M | -2.63M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -14.50M | 0.00 | 0.00 | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -14.50M | 0.00 | 0.00 | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -14.50M | -5.72M | -6.15M | -2.63M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-14.50M | 0.00 | 0.00 | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -14.50M | 0.00 | -2.09M | 0.00 |
| Basic EPS from Continuing Ops. | -0.35 | -0.21 | -0.43 | -0.19 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.35 | -0.21 | -0.43 | -0.19 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.35 | -0.21 | -0.43 | -0.19 |
| Basic Normalized Net Income/Share | -0.35 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | -0.35 | -0.21 | -0.43 | -0.19 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.35 | -0.21 | -0.43 | -0.19 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.35 | -0.21 | -0.43 | -0.19 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.35 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with IMUC
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserBiotech88
- ContributorStocks Under-$10 Setting Up...
Latest IMUC Headlines from TheStreet
- IMUC July Options Begin Trading 05.20.13 | 04:05 pm
- Biotech Stock Mailbag: Celldex, TG Therapeutics, Sarepta 03.08.13 | 06:03 am
- Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics 02.08.13 | 06:02 am
- 3 Stocks Under $5 Making Big Moves 02.05.13 | 02:02 pm
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- Biotech Stock Mailbag: Keryx, Amarin, ImmunoCellular 06.08.12 | 09:06 am
- 5 Stocks Under $10 Set to Soar 06.01.12 | 11:06 am
- 5 Stocks Under $10 Set to Soar 12.31.69 | 07:12 pm
Press Releases for IMUC
- ImmunoCellular Therapeutics To Present At Future Leaders Conference On April 5th - Business Wire 03.28.13 | 06:03 am
- ImmunoCellular Therapeutics To Present At ROTH Conference On March 18th - Business Wire 03.11.13 | 04:03 pm
- ImmunoCellular Therapeutics Announces Fourth Quarter And Full Year 2012 Financial Results - Business Wire 03.05.13 | 04:03 pm
- ImmunoCellular Therapeutics Announces Issuance Of Key Patent For ICT-121 Cancer Vaccine - Business Wire 03.04.13 | 06:03 am
- ImmunoCellular Therapeutics To Report Financial Results For The Fourth Quarter And Full Year 2012 On March 5, 2013 - Business Wire 02.26.13 | 06:02 am
- ImmunoCellular Therapeutics To Present At BIO CEO & Investor Conference On February 11th - Business Wire 02.04.13 | 04:02 pm
- ImmunoCellular Therapeutics’ Investigational New Drug (IND) Application For ICT-140 Allowed By The FDA - Business Wire 01.29.13 | 06:01 am
- ImmunoCellular Therapeutics Provides Update On Corporate Milestones - Business Wire 01.07.13 | 06:01 am
- ImmunoCellular Therapeutics Appoints Gary S. Titus To Its Board Of Directors - Business Wire 01.02.13 | 06:01 am
- ImmunoCellular Therapeutics Appoints Andrew Gengos As Chief Executive Officer - Business Wire 12.03.12 | 04:12 pm
Partner Headlines for IMUC
- ImmunoCellular Update Adds Clarity And Further Validates Investment Thesis - Seeking Alpha 03.07.13 | 09:03 am
- ImmunoCellular Therapeutics: An Opportunity For Great Upside Potential - Seeking Alpha 11.21.12 | 08:11 am
- ImmunoCellular Therapeutics Announces Pricing of its Previously Announced Public Offering of Common Stock and Warrants - Benzinga 10.18.12 | 09:10 am
- A Gold Mine In Biotechnology: The Companies Poised To Benefit - Seeking Alpha 09.04.12 | 09:09 am
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- ImmunoCellular Provides Update on Phase II Clinical Trial of ICT-107 for Treatment of Glioblastoma - Benzinga 07.02.12 | 09:07 am
- MLV & Co Reiterates Buy, $4.50 PT on ImmunoCellular Therapeutics on Move to NYSE - Benzinga 05.25.12 | 12:05 pm
- Zacks Bull and Bear of the Day Highlights: ImmunoCellular, Willis Group Holdings, Encana, Exxon Mobil and Cenovus Energy - Press Releases - Zacks 02.21.12 | 09:02 am
- ImmunoCellular (IMUC) - Bull of the Day - Zacks 02.21.12 | 01:02 am
- Biotechs to Watch at the 2012 San Francisco Healthcare Confrences - Analyst Blog - Zacks 01.09.12 | 07:01 am
